High neutrophil/lymphocyte ratio and low lymphocyte percentage are independent risk factors for new-onset CKD

Mengyuan Guo , Zhaohui Wang , Rui Yang , Kun Liu , Junchao Zeng , Tianhui An
{"title":"High neutrophil/lymphocyte ratio and low lymphocyte percentage are independent risk factors for new-onset CKD","authors":"Mengyuan Guo ,&nbsp;Zhaohui Wang ,&nbsp;Rui Yang ,&nbsp;Kun Liu ,&nbsp;Junchao Zeng ,&nbsp;Tianhui An","doi":"10.1016/j.clicom.2022.11.003","DOIUrl":null,"url":null,"abstract":"<div><p>Chronic kidney disease (CKD) is one of the major public health problems worldwide, and inflammation is a noticeable cause of CKD. A total of 5508 non-CKD patients were enrolled in our prospective study and followed for three years, with 1.25% (<em>n</em> = 69) participants having newonset CKD at the endpoint. After adjustment for potential confounders, we found that High NLR and low LYMPH% are two independent risk factors for new-onset CKD: Compared with the lowest NLR tertile, the multifactor corrected OR (95% CI) of the highest tertile was 2.47(1.20–5.09), <em>P</em> = 0.014; And adjusted OR (95% CI) was 0.31(0.16–0.62) for the highest LYMPH% tertile, <em>P</em> = 0.001. The model constructed with NLR, LYMPH%, and other risk factors had favourable predictive power for new-onset CKD with an AUC of 0.82 (95% CI, 0.76–0.88). Assessment of NLR and LYMPH% may be helpful for early warning of CKD occurrence.</p></div>","PeriodicalId":100269,"journal":{"name":"Clinical Immunology Communications","volume":"2 ","pages":"Pages 165-171"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772613422000294/pdfft?md5=f75317f6ec969ade80737d050d6208a6&pid=1-s2.0-S2772613422000294-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Immunology Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772613422000294","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Chronic kidney disease (CKD) is one of the major public health problems worldwide, and inflammation is a noticeable cause of CKD. A total of 5508 non-CKD patients were enrolled in our prospective study and followed for three years, with 1.25% (n = 69) participants having newonset CKD at the endpoint. After adjustment for potential confounders, we found that High NLR and low LYMPH% are two independent risk factors for new-onset CKD: Compared with the lowest NLR tertile, the multifactor corrected OR (95% CI) of the highest tertile was 2.47(1.20–5.09), P = 0.014; And adjusted OR (95% CI) was 0.31(0.16–0.62) for the highest LYMPH% tertile, P = 0.001. The model constructed with NLR, LYMPH%, and other risk factors had favourable predictive power for new-onset CKD with an AUC of 0.82 (95% CI, 0.76–0.88). Assessment of NLR and LYMPH% may be helpful for early warning of CKD occurrence.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中性粒细胞/淋巴细胞比值高和淋巴细胞百分比低是新发CKD的独立危险因素
慢性肾脏疾病(CKD)是世界范围内主要的公共卫生问题之一,炎症是CKD的一个显著原因。我们的前瞻性研究共纳入了5508名非CKD患者,随访3年,其中1.25% (n = 69)的参与者在终点时患有新发CKD。在对潜在混杂因素进行校正后,我们发现高NLR和低LYMPH%是新发CKD的两个独立危险因素:与最低NLR分位数相比,最高分位数的多因素校正OR (95% CI)为2.47(1.20-5.09),P = 0.014;最高淋巴百分比的校正OR (95% CI)为0.31(0.16-0.62),P = 0.001。由NLR、LYMPH%和其他危险因素构建的模型对新发CKD具有良好的预测能力,AUC为0.82 (95% CI, 0.76-0.88)。评估NLR和LYMPH%可能有助于CKD发生的早期预警。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Long-term follow-up of anti-IFN-α2 autoantibody levels in hospitalized individuals with COVID-19 CRISPR/Cas9-mediated RELA and RELC knockout in human regulatory T cells abrogates FOXP3 expression and suppressive function Deficiency of interleukin-1 receptor antagonist: An updated review of the pathogenesis, clinical characteristics, and treatments First report of Mycobacterium chimaera infection in a patient with chronic granulomatous disease Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1